Humira is a type of immunosuppressant known as a tumor necrosis factor (TNF) inhibitor. It's used to treat several types of ...

One key opportunity for growth of the hidradenitis Suppurativa market is the untapped potential found in emerging countries with growing healthcare infrastructure and treatment availability. This ...

AbbVie’s Humira was the top-selling drug in the world for many years. Now, its sales are eroding as doctors switch to ...

As with other drugs, Humira (adalimumab) can cause side effects, such as headache and injection site reactions. If you are not able to tolerate side effects of Humira, talk with your doctor or ...

At the 2025 American Academy of Dermatology (AAD) meeting, Steven Daveluy, M.D., associate professor and program director of dermatology at Wayne State University, discussed ongoing barriers to the ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Uncertainties remain about the real-world benefit of adalimumab biosimilars for psoriasis, limiting their widespread ...

WEDNESDAY, March 5, 2025 (HealthDay News) -- For patients with psoriasis, Amjevita and Imraldi are as effective as Humira for new users and in a switcher analysis, according to a study published ...

Patients with hidradenitis suppurativa with draining tunnels have significantly more clinical manifestations than those without draining tunnels, including abscesses, scarring, inflammation, drainage, ...

MALIGNANCY: Lymphoma and other malignancies, some fatal, have been reported in children and adolescent patients treated with TNF blockers including adalimumab products. Post-marketing cases of ...

In this video, dermatologist Michelle Henry, MD, shares the benefits of seeing a dermatologist for HS and how to prepare for an appointment. Judge orders Trump to reinstate fired federal workers ...

Despite being the most widely used drug in the US, Humira, known for its effectiveness ... plaque psoriasis, and hidradenitis suppurativa. RxPreferred is the second PBM to offer Yusimry.

Hidradenitis Suppurativa (HS) is a chronic suppurative disease of the pilosebaceous unit. The current model of HS pathophysiology describes the condition as the product of hyperkeratinisation and ...